Skip to menu Skip to content Skip to footer
Associate Professor David Vesey
Associate Professor

David Vesey

Email: 

Overview

Background

David graduated from the University of London with a BSc (Hons) in biochemistry (King’s College) and PhD which investigated the role of epidermal growth factor receptors in liver regeneration (Imperial College). Since then he has worked on a variety of projects including; immunoassay development (Ortho Clinical Diagnostics); artificial liver machine development (Imperial College); and p53 mutations in liver cancer (QIMR). He joined the Department of Nephrology at the Princess Alexandra Hospital in Brisbane in 1999. He is a senior lecturer in The University of Queensland Faculty of Medicine, a senior member of the UQ Kidney Disease Research Laboratory and manages the Princess Alexandra Hospital Endotoxin Testing Service.

His main research interests are in the area of renal tubulointerstitial fibrosis, inflammation and also the mechanisms of renal cancer development – particularly the role that cytokines and growth factors play in these processes. Current projects include the role of protease activated receptor-2 in renal scarring, inflammation and cancer, the mechanism of heavy metal toxicity in the kidney and the renoprotective properties of erythropoietin. The Princess Alexandra Hospital Endotoxin Testing Service routinely tests samples from dialysis units throughout Queensland.

Availability

Associate Professor David Vesey is:
Available for supervision

Fields of research

Qualifications

  • Bachelor of Biochemistry, King's College London
  • Doctor of Philosophy of Gastroenterology and Hepatology, Imperial College London

Works

Search Professor David Vesey’s works on UQ eSpace

176 works between 1991 and 2025

141 - 160 of 176 works

2005

Conference Publication

Delayed bolus administration of darbepoietin or erythropoietin protects against ischaemic acute renal injury and failure

Johnson, D., Pat, B., Vesey, D., Guan, Z., Endre, Z. and Gobe, G. (2005). Delayed bolus administration of darbepoietin or erythropoietin protects against ischaemic acute renal injury and failure. 41th [sic] Annual Scientific Meeting of the Australian and New Zealand Society of Nephrology, Wellington, New Zealand, 3-7 September 2005. Carlton, Vic.: Blackwell Science. doi: 10.1111/j.1440-1797.2005.00461.x

Delayed bolus administration of darbepoietin or erythropoietin protects against ischaemic acute renal injury and failure

2005

Conference Publication

PAR-2 activation promotes cortical fibroblast proliferation and matrix protein production: A potential role for locally expressed trypsinogen

Vesey, D., Kruger, W., Poronnik, P., Gobe, G. and Johnson, D. (2005). PAR-2 activation promotes cortical fibroblast proliferation and matrix protein production: A potential role for locally expressed trypsinogen. 41th [sic] Annual Scientific Meeting of the Australian and New Zealand Society of Nephrology, Wellington, New Zealand, 3-7 September 2005. Carlton, Vic.: Blackwell Science. doi: 10.1111/j.1440-1797.2005.00461.x

PAR-2 activation promotes cortical fibroblast proliferation and matrix protein production: A potential role for locally expressed trypsinogen

2005

Conference Publication

Role of PKC-a and -e in cytotoxic chemotherapy of renal cell carcinomas

Gobe, G., Li, J., Pat, B., Yan, J., Vesey, D., Johnson, D. and Nicol, D. (2005). Role of PKC-a and -e in cytotoxic chemotherapy of renal cell carcinomas. 41th [sic] Annual Scientific Meeting of the Australian and New Zealand Society of Nephrology, 4-8 September 2005, Carlton, Victoria. Blackwell Science: 1320-5358 (print); 1440-1797 (electronic). doi: 10.1111/j.1440-1797.2005.00461.x

Role of PKC-a and -e in cytotoxic chemotherapy of renal cell carcinomas

2005

Conference Publication

Therapeutic value of orally administered silibinin in renal cell carcinoma: Manipulation of IGFBP-3 levels

Vesey, D., Cheung, C., Taylor, P., Kirkpatirick, C., Gobe, G., Winterford, C., Nicol, D. and Johnson, D. (2005). Therapeutic value of orally administered silibinin in renal cell carcinoma: Manipulation of IGFBP-3 levels. 41st Annual Scientific Meeting of the Australian and New Zealand Society of Nephrology, Wellington, New Zealand, 3-7 September 2005. Carlton, Victoria: Blackwell Science. doi: 10.1111/j.1440-1797.2005.00461.x

Therapeutic value of orally administered silibinin in renal cell carcinoma: Manipulation of IGFBP-3 levels

2004

Journal Article

The roles of IGF-I and IGFBP-3 in the regulation of proximal tubule, and renal cell carcinoma cell proliferation

Cheung, Catherine W., Vesey, David A., Nicol, David L. and Johnson, David W. (2004). The roles of IGF-I and IGFBP-3 in the regulation of proximal tubule, and renal cell carcinoma cell proliferation. Kidney International, 65 (4), 1272-1279. doi: 10.1111/j.1523-1755.2004.00535.x

The roles of IGF-I and IGFBP-3 in the regulation of proximal tubule, and renal cell carcinoma cell proliferation

2004

Journal Article

Erythropoietin protects against ischaemic acute renal injury

Vesey, David A., Cheung, Catherine, Pat, Betty, Endre, Zoltan, Gobe, Glenda and Johnson, David W. (2004). Erythropoietin protects against ischaemic acute renal injury. Nephrology Dialysis Transplantation, 19 (2), 348-355. doi: 10.1093/ndt/gfg547

Erythropoietin protects against ischaemic acute renal injury

2004

Conference Publication

Chemotherapy induced apoptosis in renal carcinomas versus normal renal tubular epithelium: Role of PKCs

Li, J., Pat, B., Yang, T., Vesey, D., Johnson, D. W. and Gobe, G. C. (2004). Chemotherapy induced apoptosis in renal carcinomas versus normal renal tubular epithelium: Role of PKCs. 40th Annual Scientific Meeting of the Australian and New Zealand Society of Nephrology, Adelaide Convention Centre, Adelaide, Australia, 1–3 September, 2004. Carlton, Vic. Australia: Blackwell Science. doi: 10.1111/j.1440-1797.2004.00264.x

Chemotherapy induced apoptosis in renal carcinomas versus normal renal tubular epithelium: Role of PKCs

2004

Conference Publication

Par-2 activation mediates pro-inflammatory and proliferative responses in renal proximal tubule cells

Vesey, D. A., Cheung, C. W., Kruger, W., Poronnik, P., Gobé, G. C. and Johnson, D. W. (2004). Par-2 activation mediates pro-inflammatory and proliferative responses in renal proximal tubule cells. 40th Annual Scientific Meeting of the Australian and New Zealand Society of Nephrology, Adelaide Convention Centre, Adelaide, Australia, 1–3 September, 2004. Carlton, Vic. Australia: Blackwell Science. doi: 10.1111/j.1440-1797.2004.00264.x

Par-2 activation mediates pro-inflammatory and proliferative responses in renal proximal tubule cells

2004

Conference Publication

Silibinin inhibits renal cell carcinoma cell growth via an insulin-like growth factor (IGFBP-3) independent pathway

Cheung, C. W., Vesey, D. A., Nicol, D. L. and Johnson, D. W. (2004). Silibinin inhibits renal cell carcinoma cell growth via an insulin-like growth factor (IGFBP-3) independent pathway. 40th Annual Scientific Meeting of the Australian and New Zealand Society of Nephrology, Adelaide Convention Centre, Adelaide, Australia, 1–3 September, 2004. Carlton, Vic. Australia: Blackwell Science. doi: 10.1111/j.1440-1797.2004.00264.x

Silibinin inhibits renal cell carcinoma cell growth via an insulin-like growth factor (IGFBP-3) independent pathway

2003

Conference Publication

Renal cell carcinoma growth is regulated by autocrine insulin-like growth factor-I (IGF-I) and insulin-like growth factor binding protein-3 (IGFBP-3) action

Cheung, C. W., Vesey, D. A., Nicol, D. L. and Johnson, D. W. (2003). Renal cell carcinoma growth is regulated by autocrine insulin-like growth factor-I (IGF-I) and insulin-like growth factor binding protein-3 (IGFBP-3) action. 39th Annual Scientific Meeting of the Australian and New Zealand Society of Nephrology, Perth, Australia, 31 August - 3 September 2003. Carlton South, Australia: Blackwell Publishing Asia. doi: 10.1046/j.1440-1797.8.s3.1.x

Renal cell carcinoma growth is regulated by autocrine insulin-like growth factor-I (IGF-I) and insulin-like growth factor binding protein-3 (IGFBP-3) action

2003

Conference Publication

Role of PKC-a and -e in cytotoxic chemotherapy of renal cell carcinomas

Li, J., Pat, B., Yan, J., Vesey, D. A., Johnson, D. W., Nicol, D. and Gobe, G. C. (2003). Role of PKC-a and -e in cytotoxic chemotherapy of renal cell carcinomas. 39th Annual Scientific Meeting of the Australian and New Zealand Society of Nephrology, Perth, WA, Australia, 31 August- 3 September, 2003. Carlton South, Australia: Blackwell Publishing Asia. doi: 10.1046/j.1440-1797.8.s3.1.x

Role of PKC-a and -e in cytotoxic chemotherapy of renal cell carcinomas

2003

Conference Publication

Activation of protease-activated receptors (PAR) on cultured human proximal tubular cells (PAR) mediates inflammatory and fibroproliferative responses

Vesey, D. A., Cheung, C. W., Gobe, G. C. and Johnson, D. W. (2003). Activation of protease-activated receptors (PAR) on cultured human proximal tubular cells (PAR) mediates inflammatory and fibroproliferative responses. 39th Annual Scientific Meeting of the Australian and New Zealand Society of Nephrology, Perth, W. A., 31 August- 3 September, 2003. Carlton South, Australia: Blackwell Publishing Asia. doi: 10.1046/j.1440-1797.8.s3.1.x

Activation of protease-activated receptors (PAR) on cultured human proximal tubular cells (PAR) mediates inflammatory and fibroproliferative responses

2003

Conference Publication

Renal cell carcinoma growth is regulated by autocrine insulin-like growth factor-I (IGF-I) and insulin-like growth factor binding protein-3 (IGFBP-3) action

Cheung, Catherine, Vesey, David, Nicol, David and Johnson, David (2003). Renal cell carcinoma growth is regulated by autocrine insulin-like growth factor-I (IGF-I) and insulin-like growth factor binding protein-3 (IGFBP-3) action. The World Congress of Nephrology, Berlin, Germany, 8-12 June, 2003. Oxford, England: Oxford University Press.

Renal cell carcinoma growth is regulated by autocrine insulin-like growth factor-I (IGF-I) and insulin-like growth factor binding protein-3 (IGFBP-3) action

2003

Conference Publication

Thrombin stimulates pro-inflammatory and fibro-proliferative response in cultured human proximal tubule cells

Vesey, D. A., Cheung, C., Gobe, G. and Johnson, D. W. (2003). Thrombin stimulates pro-inflammatory and fibro-proliferative response in cultured human proximal tubule cells. Annual Queensland Health and Medical Scientific Meeting, Brisbane, Qld, Australia, 25-26 November, 2003. Brisbane, Qld, Australia: Queensland Health.

Thrombin stimulates pro-inflammatory and fibro-proliferative response in cultured human proximal tubule cells

2003

Conference Publication

Thrombin stimulates inflammatory and fibro-proliferative responses in cultured human proximal tubule cells

Vesey, D. A., Cheung, C. W., Gobe, G. C. and Johnson, D. W. (2003). Thrombin stimulates inflammatory and fibro-proliferative responses in cultured human proximal tubule cells. 39th Annual Scientific Meeting of the Australian and New Zealand Society of Nephrology, Perth, W. A., 31 August- 3 September, 2003. Carlton South, Australia: Blackwell Publishing Asia. doi: 10.1046/j.1440-1797.8.s3.1.x

Thrombin stimulates inflammatory and fibro-proliferative responses in cultured human proximal tubule cells

2002

Journal Article

Interleukin-1 beta stimulates human renal fibroblast proliferation and matrix protein production by means of a transforming growth factor-beta-dependent mechanism

Vesey, David A., Cheung, Catherine, Cuttle, Leila, Endre, Zoltan, Gobe, Glenda and Johnson, David W. (2002). Interleukin-1 beta stimulates human renal fibroblast proliferation and matrix protein production by means of a transforming growth factor-beta-dependent mechanism. Journal of Laboratory And Clinical Medicine, 140 (5), 342-350. doi: 10.1067/mlc.2002.128468

Interleukin-1 beta stimulates human renal fibroblast proliferation and matrix protein production by means of a transforming growth factor-beta-dependent mechanism

2002

Journal Article

Interleukin-1 beta induces human proximal tubule cell injury, alpha-smooth muscle actin expression and fibronectin production

Vesey, D. A., Cheung, C. W. Y., Cuttle, L., Endre, Z. A., Gobe, G. and Johnson, D. W. (2002). Interleukin-1 beta induces human proximal tubule cell injury, alpha-smooth muscle actin expression and fibronectin production. Kidney International, 62 (1), 31-40. doi: 10.1046/j.1523-1755.2002.00401.x

Interleukin-1 beta induces human proximal tubule cell injury, alpha-smooth muscle actin expression and fibronectin production

2002

Journal Article

Angiotensin converting enzyme inhibitors protect against renal injury via direct effects on the tubulointerstitium: evidence from cell cultures

Johnson, D. W. and Vesey, D. A. (2002). Angiotensin converting enzyme inhibitors protect against renal injury via direct effects on the tubulointerstitium: evidence from cell cultures. Health Science, 11 (3), 14-15.

Angiotensin converting enzyme inhibitors protect against renal injury via direct effects on the tubulointerstitium: evidence from cell cultures

2002

Conference Publication

Insulin-like growth factor (IGF)-I stimulates in vitro human renal cell carcinoma (RCC) growth

Cheung, C., Vesey, D. A., Gobe, G., Nicol, D. L. and Johnson, D. W. (2002). Insulin-like growth factor (IGF)-I stimulates in vitro human renal cell carcinoma (RCC) growth. Australian and New Zealand Society of Nephrology 37th Annual Scientific Meeting, Darwin, Australia, 5-7 September, 2001. Carlton, Vic.: Blackwell Science. doi: 10.1046/j.1440-1797.2002.00007-1-15.x

Insulin-like growth factor (IGF)-I stimulates in vitro human renal cell carcinoma (RCC) growth

2001

Journal Article

Human adipose tissue endothelial cells promote preadipocyte proliferation

Hutley, L. J., Herington, A. C., Shurety, W., Cheung, C., Vesey, D. A., Cameron, D. P. and Prins, J. B. (2001). Human adipose tissue endothelial cells promote preadipocyte proliferation. American Journal of Physiology - Endocrinology and Metabolism, 281 (5), E1037-E1044. doi: 10.1152/ajpendo.2001.281.5.E1037

Human adipose tissue endothelial cells promote preadipocyte proliferation

Funding

Past funding

  • 2013 - 2015
    The application of adipose-derived stem cells and stem cell secretions to the treatment of renal disease.
    UQ Academic Title Holder Research Fund
    Open grant
  • 2010 - 2013
    Enhancing erythropoietin therapy in ischaemia-reperfusion injury of heart and kidney
    NHMRC Project Grant
    Open grant
  • 2010 - 2012
    Protease activated receptor 2 antagonist in inflammatory disease
    NHMRC Development Grant
    Open grant
  • 2009 - 2012
    Protease Activated Receptor 2 : A New Drug Target For Inflammatory Diseases and Cancer
    NHMRC Project Grant
    Open grant

Supervision

Availability

Associate Professor David Vesey is:
Available for supervision

Before you email them, read our advice on how to contact a supervisor.

Supervision history

Current supervision

Completed supervision

Media

Enquiries

For media enquiries about Associate Professor David Vesey's areas of expertise, story ideas and help finding experts, contact our Media team:

communications@uq.edu.au